Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Viguera

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Journal of Clinical Psychopharmacology|February 24, 2023
Risk of Major Malformations Following First-Trimester Exposure to Olanzapine: Preliminary Data From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric MedicationsAdele C Viguera, Marlene P Freeman, Lauren A Kobylski, et al.
Psychosomatics|March 28, 2018
Prevalence and Predictors of Depression Among Patients With Epilepsy, Stroke, and Multiple Sclerosis Using the Cleveland Clinic Knowledge Program Within the Neurological InstituteAdele C Viguera, Youran Fan, Nicolas R Thompson, et al.
The American Journal of Psychiatry|August 17, 2018
Risk of Major Malformations in Infants Following First-Trimester Exposure to QuetiapineLee S Cohen, Lina Góez-Mogollón, Alexandra Z Sosinsky, et al.
General Hospital Psychiatry|November 13, 2021
Perinatal experiences of pregnant women with psychiatric disorders during the COVID-19 pandemicAnna Feeney, Rebecca S Hock, Heather A Harmon, et al.
Annals of Clinical and Translational Neurology|June 3, 2014
MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATIONAkshanth R Polepally, Page B Pennell, Richard C Brundage, et al.
Pediatrics|July 2, 2008
Lamotrigine in breast milk and nursing infants: determination of exposureD Jeffrey Newport, Page B Pennell, Martha R Calamaras, et al.
Archives of Women'S Mental Health|September 1, 2004
Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective studyL S Cohen, R M Nonacs, J W Bailey, et al.
The Journal of Clinical Psychiatry|August 29, 2018
Psychiatric Medications and Reproductive Safety: Scientific and Clinical Perspectives Pertaining to the US FDA Pregnancy and Lactation Labeling RuleMarlene P Freeman, Tiffany Farchione, Lynn Yao, et al.
Depression and Anxiety|August 1, 2022
Risk of major malformations in infants after first-trimester exposure to benzodiazepines: Results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric MedicationsMercedes J Szpunar, Marlene P Freeman, Lauren A Kobylski, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 17, 2023
Stressors and coping mechanisms among pregnant women with psychiatric disorders during the COVID-19 pandemicRebecca S Hock, Anna Feeney, Heather A Harmon, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Journal of Clinical Psychopharmacology|February 24, 2023
Risk of Major Malformations Following First-Trimester Exposure to Olanzapine: Preliminary Data From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric MedicationsAdele C Viguera, Marlene P Freeman, Lauren A Kobylski, et al.
Psychosomatics|March 28, 2018
Prevalence and Predictors of Depression Among Patients With Epilepsy, Stroke, and Multiple Sclerosis Using the Cleveland Clinic Knowledge Program Within the Neurological InstituteAdele C Viguera, Youran Fan, Nicolas R Thompson, et al.
The American Journal of Psychiatry|August 17, 2018
Risk of Major Malformations in Infants Following First-Trimester Exposure to QuetiapineLee S Cohen, Lina Góez-Mogollón, Alexandra Z Sosinsky, et al.
General Hospital Psychiatry|November 13, 2021
Perinatal experiences of pregnant women with psychiatric disorders during the COVID-19 pandemicAnna Feeney, Rebecca S Hock, Heather A Harmon, et al.
Annals of Clinical and Translational Neurology|June 3, 2014
MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATIONAkshanth R Polepally, Page B Pennell, Richard C Brundage, et al.
Pediatrics|July 2, 2008
Lamotrigine in breast milk and nursing infants: determination of exposureD Jeffrey Newport, Page B Pennell, Martha R Calamaras, et al.
Archives of Women'S Mental Health|September 1, 2004
Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective studyL S Cohen, R M Nonacs, J W Bailey, et al.
The Journal of Clinical Psychiatry|August 29, 2018
Psychiatric Medications and Reproductive Safety: Scientific and Clinical Perspectives Pertaining to the US FDA Pregnancy and Lactation Labeling RuleMarlene P Freeman, Tiffany Farchione, Lynn Yao, et al.
Depression and Anxiety|August 1, 2022
Risk of major malformations in infants after first-trimester exposure to benzodiazepines: Results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric MedicationsMercedes J Szpunar, Marlene P Freeman, Lauren A Kobylski, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 17, 2023
Stressors and coping mechanisms among pregnant women with psychiatric disorders during the COVID-19 pandemicRebecca S Hock, Anna Feeney, Heather A Harmon, et al.
Pageof 10